Helicobacter pylori: identification and detection of clarithromycin resistance by gene amplification
Sevin, E.; Lamarque, D.; Delchier, J.C.; Soussy, C.J.; Tankovic, J.
Annales de Biologie Clinique 58(1): 81-84
2000
ISSN/ISBN: 0003-3898 PMID: 10673617 Document Number: 514149
Document emailed within 1 workday
Related Documents
Maeda, S.; Yoshida, H. 1999: Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 87-92Radosz-Komoniewska, H.M.; Romańczyk, T.; Nowakowska, M.; Nowak, A.; Martirosian, G. 2004: Comparison of diagnostic methods for Helicobacter pylori detection and identification of cagA gene in clinical specimens Wiadomosci Lekarskie 57(11-12): 617-622
Zheng, X.-L.; Hu, F.-L.; Wang, W.-H.; Xu, L. 2009: Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains Zhonghua Yi Xue Za Zhi 89(22): 1558-1562
Tüzün, Y.; Bayan, K.; Yilmaz, S.; Dursun, M.; Ozekinci, T. 2008: The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia Hepato-Gastroenterology 55(81): 289-293
Hansomburana, P.; Anantapanpong, S.; Sirinthornpunya, S.; Chuengyong, K.; Rojborwonwittaya, J. 2012: Prevalence of single nucleotide mutation in clarithromycin resistant gene of Helicobacter pylori: a 32-months prospective study by using hybridization real time polymerase chain reaction Journal of the Medical Association of Thailand 95(Suppl 3): S28-S35
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Gómez, J.; Elizalde, J.I.; Marco, F.; Bordas, J.M.; Piqué, J.M.; Jiménez de Anta, M.T. 1999: Typification of strains of Helicobacter pylori by the detection of the cagA gene and subtypes of the vacA gene Enfermedades Infecciosas y Microbiologia Clinica 17(4): 171-175
Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Liu, W.; Zhu, J.; Liu, Y.; Wang, Y.; Wang, Y.; Wang, X. 2019: Effects of addition of probiotic and/or bismuth to triple therapy of H. pylori and analysis of genetic variation of 23S rRNA gene between patients with clarithromycin sensitivity and resistance Pakistan Journal of Pharmaceutical Sciences 32(3 Special): 1321-1326
Schepp, W. 1995: Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori Zeitschrift für Gastroenterologie 33(10): 621-623
Frotz, H.; Ahrends, H.; Hebbeln, H.; Klass, D.; Miederer, S.E.; Mittelstaedt, A.; Rolfs, H.C.; von Geldern, R. 1995: Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer Arzneimittel-Forschung 45(2): 184-186
Chey, W.D.; Fisher, L.; Elta, G.H.; Barnett, J.L.; Nostrant, T.; DelValle, J.; Hasler, W.L.; Scheiman, J.M. 1997: Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial American Journal of Gastroenterology 92(9): 1483-1486
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Adamek, R.J.; Opferkuch, W.; Wegener, M. 1995: Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 168-169
Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Ye, Y.; Wu, J.; Luo, H.-b.; Wang, Z.; Li, Y.-b. 2008: Multiple amplification of 16S rRNA gene and Cytb gene in mitochondrial DNA for species identification Fa Yi Xue Za Zhi 24(4): 259-261
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Dzierzanowska, D.; Gzyl, A.; Rozynek, E.; Augustynowicz, E.; Wojda, U.; Celińska-Cedro, D.; Sankowska, M.; Wadström, T. 1996: PCR for identification and typing of Helicobacter pylori isolated from children Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 47(1): 101-114
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296